City of Hope Medical Center
Duarte, California, 91010, United States
NCT Number: NCT05414396
This clinical trial tests the Eat, Move, Live (EML) Program in reducing the risk of chronic diseases among underserved communities by improving healthy lifestyle practices, increasing physical activity and encouraging healthy eating behaviors. EML is a series of free culturally and linguistically appropriate nutrition and physical activity sessions. The interactive education segment of the EML Program is culturally responsive, and based on the community EML program, and topics will include: nutrition guidelines, reading food labels, recipe modification and healthy food preparation, eating healthy on a budget, chronic diseases information and prevention strategies. The EML program may help reduce the risk of cancer and chronic diseases by encouraging more physical activity and healthy eating behaviors.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Duarte, California, 91010, United States
PRIMARY OBJECTIVES:
I. To evaluate program by assessing in combination with standard of care metformin: Changes in participants' knowledge, attitudes, and behavior.
II. To evaluate program by assessing in combination with standard of care metformin: Changes in body measurements.
III. To evaluate program by assessing in combination with standard of care metformin: Changes in biomarkers.
OUTLINE:
Participants attend EML program sessions weekly for 12 weeks including an educational session chronic disease risk reduction via nutrition and physical activity, a physical activity session, and a cooking/taste test demonstration.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Attend EML program sessions
Other names: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments
Ancillary studies
Time frame: Baseline and week 12
Attitudes and beliefs regarding causes of diabetes asked in questionnaire, measured by endorsing one of the Likert-type scale values ranging from 1 (Agree) to 7 (Disagree).
Time frame: Baseline and week 12
Behaviors related to food consumption asked in questionnaires, measured by endorsing one of "None", "1", "2-3", "4-6", "7 or more".
Time frame: Baseline to 12 weeks
Height measured in meters
Time frame: Baseline to 12 weeks
Weight measured in Kilograms
Time frame: Baseline to 12 weeks
Hip circumference measured in centimeters
Time frame: Baseline to 12 weeks
Chest circumference measured in centimeters
Time frame: Baseline to 12 weeks
Right upper arm circumference measured in centimeters
Time frame: Baseline to 12 weeks
Left upper arm circumference measured in centimeters
Time frame: Baseline to 12 weeks
Right upper thigh circumference measured in centimeters
Time frame: Baseline to 12 weeks
Left upper thigh circumference measured in centimeters
Time frame: Baseline to 12 weeks
Body fat percentage measured in percent using a handheld BMI machine that calculates body fat percentage.
Time frame: Baseline to 12 weeks
Systolic blood pressure measured in mmHG
Time frame: Baseline to 12 weeks
Diastolic blood pressure measured in mmHG
Time frame: Baseline to 12 weeks
Hip circumference measured in centimeters
Time frame: Baseline to 12 weeks
Will be collected at baseline and follow up based on glycosylated hemoglobin (A1C) measuring guidelines.
City of Hope Medical Center
Other
Reducing Cancer and Chronic Disease Risk in Underserved Communities: Eat, Move, Live Program
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT03520660
Adenocarcinoma, Blood-Borne Infections
Bethesda, Maryland, United States
View Trial DetailsNCT06587438
Diabetes Mellitus, Endocrine System Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07039942
Autoimmune Diseases, Diabetes
Angers, France
View Trial Details